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INTRODUCTION
Miana leaves (Coleus scutellariodes [L] Benth) are 
a herbal medicine and at the molecular level exhibit 
anti-inflammatory properties in patients infected with 
vulvovaginal candidiasis caused by Candida albicans. 
The importance of herbal medicines in the treat-
ment of vulvovaginal candidiasis has previously been 
reported.1
C. albicans is a fungus that constitutes part of the nor-
mal human microbiome but in certain circumstances 
can cause systemic candidiasis infections.2 That may 
be life threatening.3 The mechanisms involved in the 
spread of C. albicans infection are not fully under-
stood, and the classification of antifungal medicines is 
incomplete.4,5 The increasing number of C. albicans 
strains that are resistant to the azole class of antibiot-
ics is a challenge in the treatment of candidiasis.6 In 
addition, the use of certain antibiotics, such as deriva-
tives of imidazole, nystatin, amphotericin, and keto-
conazole, can cause side effects such as nausea and 
dizziness.7 In many developing countries, especially 
Indonesia, people believe that alternative treatments 
using natural materials such as miana leaves can be 
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Background: Miana (Coleus scutellariodes (L) Benth) are a herbal medicine with potential 
anti-inflammatory properties in patients infected with vulvovaginal candidiasis. The objective 
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the expression of IL-37. Results: These findings indicated that a component within MLE may 
mediate its anti-inflammatory characteristics, as indicated by the increase in mRNA IL-37 
expression in mice inoculated with C. albicans. The highest increase in fungal load to 101.6 
CFU was observed in the placebo group at day 14. Whereas for the mice treated with MLE 
at 750 mg/kg b.w, the fungal load only increased to 30.0 CFU, similar to that of mice treated 
with ketoconazole (29.6 CFU). In the mice treated with MLE at 500 mg/kg b.w, the fungal 
load increased to 68.2 CFU. Conclusion: Fungiostatic effect of MLE 750 mg/kg BB is not less 
than ketoconazole and MLE may act as anti-inflammatory throught its role as an antioxidant 
so it could potentially be used as an alternative treatment in humans especially patients with 
vulvovaginal candidiasis.
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effective in the treatment of diseases caused by fungi 
or bacteria.
In vitro research has been show to exhibit anti 
oxidative, anti-inflammatory and anti alergi activita-
sin mammalian system. An ample amount of work 
has been reported on micro propagation of different 
Coleus spp. From different plant like shoot tips, leaf 
segment, nodal and intermodal segments.8 Immu-
nostimulant therapy with MLE, which is thought to 
possess anti-inflammatory properties, is the latest 
approach in alternative medicine to treat vulvovagi-
nal candidiasis infection without any known side 
effects. This is a promising approach considering 
that the disease remains prevalent in Indonesia.
It has recently been reported that the cytokine 
interleukin-37 (IL-37) is an immune mediator with 
anti-inflammatory activity.9 And this cytokine IL-1 
derivative has been identified as a natural inhibitor 
of the non-specific immune system.10 The mechanism 
of action of cytokine IL-37 remains elusive but its 
pro-inflammatory properties have been reported to 
be induced in transgenic mice in response to lipo-
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polysaccharide.11 In this study, the relationship between MLE and IL-37 




Miana leaves were obtained from the Research Institute for Spices 
and Medicinal Plants (Balai Penelitian Tanaman Rempah and Obat 
(BALITRO), Bogor, Indonesia). The leaves were subjected to an extraction 
process using ethanol as the solvent in accordance with a method 
reported.12 The MLE obtained was used at doses of 500 and 750 mg/kg 
b.w.
Experimental animals and immune response test 
observations
Balb/c mice (aged 8–12 weeks, weighing 30–40 grams; n=25) were 
maintained in the Molecular Biology and Immunology Laboratory, 
Microbiology Department Faculty of Medicine, Hasanuddin University 
(Makassar, Indonesia). The mice were acclimatized for 8 days, then 
divided into five groups (n=5). Four of the groups were intravaginally 
inoculated with C. albicans ATCC 10231 (10-2/ml) and were designated: 
CVM500 (candidiasis vulvovaginal group with an MLE dose of 500 mg/
kg b.w), CVM750 (candidiasis vulvovaginal group with an MLE dose 
of 750 mg/kg b.w), CV Placebo (candidiasis vulvovaginal group with 
0.2 mL of oral normal saline through a cannula), CVC200 (candidiasis 
vulvovaginal group with a cetoconazole dose of 200 mg/kg b.w); the 
other group, M500, was not inoculated with C. albicans and constituted 
the healthy control group, receiving an MLE dose of 500 mg/kg b.w. 
Immune test responses were observed in the mice over 14 days. MLE was 
orally administered through a cannula. Blood sampling was performed 
through a submaxillary vein five times in all groups, on day zero before 
transvaginal C. albicans inoculation (S0), and on days 2, 3, 5, and 14. 
Fungi load examination
The fungal load was examined by taking a vaginal swab, diluting, and 
then culturing in a cup for 2, 3, 5, and 14 days. After culturing the number 
of colonies were counted.
RNA extraction and quantitative real-time PCR
Total mRNA was isolated from blood samples using standard methods 
and was then kept at −80°C before quantitative real-time RT-PCR using 
a commercial kit (Applied Biosystems) according to the manufacturer’s 
instructions. Primers used for amplification of the IL-37 gene were 
forward: 5′-CAGCCTCTGCGGAGAAAGGAAGT-3′, andreverse:5′-
GTTTCTCCTT CTTCAGCTGAAGGGATGGAT-3′, GAPDH forward: 
5′-ATGAGTATGCCTGCCGTGTG-3′, and GAPDH reverse: 5′-CCAAAT-
GCGGCATCTTCAAAC-3′. Expression of the GAPDH gene was analyzed 
as a control.9 All PCRs were repeated three times and the data 
were analyzed using the instrument detection system Mx4000 and 
the comparative threshold cycle method. A standard curve was 
constructed (Applied Biosystems) and indicated good amplification 
efficiency (90%–100%).
Statistical analysis
Data are expressed as the mean ± SE. To assess differences in IL-37mRNA 
expression between groups the ANOVA test was employed using the 
SPSS 23 software. Statistical significance was considered as p<0.05.
Ethics statement
This study was approved by the Health Medical Research Ethics Com-
mittee at the Faculty of Medicine, Hasanuddin University (Makassar, 
Indonesia) with registration number UH16010010, 11 March 2016.
RESULTS
Our results showed that Balb/c mice inoculated with C. albicans and 
an MLE dose of 750 mg/kg b.w. (CVM750) had significantly increased 
IL-37 mRNA expression (p>0.05) compared with those treated with 
500 mg/kg b.w. MLE (CVM500) after 14 days of treatment; the placebo 
group showed no significant increase (Figure 1). The healthy control 
mice (M500) showed no alterations in IL-37 mRNA expression, despitean 
MLE dose of 500 mg/kg b.w. interestingly, the increase in mRNA IL-37 
expression in the CVM750 group was similar to that observed in mice 
treated with ketoconazole (CVC200). These findings indicated that a 
component within MLE may mediate its anti-inflammatory character-
istics, as indicated by the increase in mRNA IL-37expression in mice 
inoculated with C. albicans.
Figure 1: IL-37 mRNA expression in the five groups of Balb/c mice.  
One-way ANOVA revealed no significant differences in IL-37 mRNA  
expression between the treatment groups on day 0 (baseline) (p=0.234) 
but significant differences were detected on days 2, 3, 5, and 14 (p=0.001).
Figure 2: Fungal load in the five groups of Balb/c mice. The mean fungal 
load in all of the treatment groups induced by C. albicans showed a 
significant difference (p=0.001) between days 2, 3, 5, and 14.
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The highest increase in fungal load to 101.6 CFU was observed in 
the placebo group at day 14. Whereas for the mice treated with MLE at 
750 mg/kg b.w, the fungal load only increased to 30.0 CFU, similar to 
that of mice treated with ketoconazole (29.6 CFU). In the mice treated 
with MLE at 500 mg/kg b.w, the fungal load increased to 68.2 CFU 
(Figure 2).
DISCUSSION
C. albicans is a major cause of vulvovaginitis, which is associated with 
the loss of acidity in the female genital area.13 The main source of this 
fungus is the normal flora in the human body and infection is often linked 
to immunosuppression.14 In immunosuppressed patients, an increased 
incidence of fungal species can lead to fungemia.15 To provide an optimal 
and efficient immune response, the body requires antioxidants to prevent 
and eliminate pathogen invasion.16 Antioxidants such as flavonoids con-
tained within MLE have been reported to increase the number of CD4+ 
T-cells and IFN-γ levels, and decrease the number of Mycobacterium 
tuberculosis colonies in the infected lungs of Wistar mice.12 A natural 
substance containing flavonoids has the potential to inhibit the produc-
tion of prostaglandin, a pro-inflammatory signaling molecule.17
The findings of our study provided evidence that MLE intervention at 
a dose of 750 mg/kg b.w. can inhibit the increase in fungal load following 
challenge with C. albicans, indicating that MLE may be exerting 
anti-fungal activity. The high fungal load (101.6 CFU) on day 14 in the 
placebo group indicated that following C. albicans challenge, mice not 
treated with MLE failed to control the infection.
Immunostimulanttherapy with MLE may therefore offer a promising 
alternative to antibiotics for the treatment of vulvovaginalcandidiasis 
infection without any known side effects. Our findings indicated that 
treatment with MLE at a dose of 750 mg/kg b.w. significantly increased 
IL-37mRNA expression in the mouse model of candidiasis vulvovaginalis 
(Figure 1), similar to treatment with ketoconazole 200 mg/kg b.w. 
Conversely, the placebo group showed no increase in the IL-37mRNA 
expression level. It is therefore likely that MLE contains an anti-inflam-
matory component that induces IL-37mRNA expression in mice.
The mechanism of action of IL-37 remains to be fully elucidated but 
IL-37 expression has been shown to suppress pro-inflammatory cytokines 
in experimental animals.11 And exert anti-inflammatory activities.18 
IL-37 is cytogenetically located on chromosome 2q13 and its encoded 
protein comprises 192 amino acids.19 IL-37 is also thought to play a role 
in dendritic cell regulation, coordinating with the immune response to 
form a new antigen.20 IL-37 expression in the tissues of patients with 
inflammatory and autoimmune diseases was reported and one study 
showed that the anti-inflammatory active components (triptolide and 
triptonide) regulated by IL-37 most likely operated via the ERK1/2 path-
way and p38 MAPK activation.21 IL-37 expression in macrophages and 
epithelial cells inhibited pro-inflammatory cytokine synthesis, and hence 
suppressed inflammation and immunity in various diseases.22 Increased 
production of IL-37 by macrophages and spleen cells was reported to 
significantly reduce the production of TNF-α during inflammation in 
mice affected by colitis.22  The consistent increase in IL-37 in spleen cells 
correlated with the increase in production of anti-inflammatory cyto-
kine IL-10 when exposed to the Candida fungus.23
CONCLUSION
MLE (at a dose of 750 mg/kg b.w.) significantly increased IL-37 mRNA 
expression and inhibited the increase in fungal load in the mouse model 
of candidiasis vulvovaginalis. The anti-inflammatory properties of MLE 
indicate that this herbal medicine could be a promising alternative 
therapy to the use of antibiotics for patients infected with vulvovaginal 
candidiasis.  
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• MLE (at a dose of 750 mg/kg b.w.) significantly increased IL-37 mRNA expres-
sion and inhibited the increase in fungal load in the mouse model of candidiasis 
vulvovaginalis. The anti-inflammatory properties of MLE indicate that this herbal 
medicine could be a promising alternative therapy to the use of antibiotics for 
patients infected with vulvovaginal candidiasis.
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